Joe Rogan Experience #2537 - David Sinclair · Aired Aug 7, 2026
Claim summary · not a verbatim quotation
Sinclair says his lab can take skin cells from a 92-year-old and, using OSK genes, bring them back to a biological equivalent of about 25 years old.
The finding
What the evidence shows
Sinclair's lab has published peer-reviewed work showing that OSK and chemical cocktails partly reverse the age of human skin-type cells (fibroblasts). In the 2023 Aging paper, four days of OSK restored nearly half of the genes that change with senescence, and the chemical cocktails lowered measured cell age by a few years. I could not find any published dataset showing 92-year-old human skin cells brought back to about 25. That figure comes from Sinclair describing his lab's work on the podcast, so it is unpublished and shouldn't be treated as a demonstrated result. A paper or preprint from his lab showing old-donor skin cells measured at roughly 25 on an aging clock would flip this verdict.
Read the supporting source · www.aging-us.com ↗Quick answer & review status
Quick answer
Is it true that Sinclair says his lab can take skin cells from a 92-year-old and, using OSK genes, bring them back to a biological equivalent of about 25 years old?
Partly. The claim stretches what the evidence shows. Sinclair's lab has published peer-reviewed work showing that OSK and chemical cocktails partly reverse the age of human skin-type cells (fibroblasts). David Sinclair said it (matched by voice) on Joe Rogan Experience #2537 - David Sinclair, aired Aug 7, 2026, at 30:14. The supporting source is aging-us.com, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.